Muscle Strength
Pulmonary rehabilitation improves training in cystic fibrosis lung transplant candidates
Between the first week of pulmonary rehabilitation and the last recorded session before transplantation, lung transplant candidates with cystic fibrosis had maintained or increased their rehabilitation measures, according to study data.
Muscle strength, cardiorespiratory fitness linked to lower mortality for those with cancer
High muscle strength and cardiorespiratory fitness reduced mortality for people diagnosed with cancer, according to a systematic review and meta-analysis.
Tofersen improves functional independence in SOD-1 ALS
Treatment with tofersen in patients with superoxide 1 dismutase 1 ALS was linked to preservation of motor function, maintenance of muscle strength and reduction of disease-specific biomarkers, data show.
Imlifidase rapidly improves mobility, muscle strength in Guillain-Barré syndrome
Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals diagnosed with Guillain-Barré syndrome led to faster muscle strength recovery and mobility.
Isokinetic strength testing may predict return to sport after Latarjet surgery
According to results published in the American Journal of Sports Medicine, isokinetic strength testing may predict return to sport outcomes for athletes who undergo a Latarjet procedure for glenohumeral instability.
Intervention mixing yoga, Mediterranean diet shows benefits in older adults
An intervention combining yoga and the Mediterranean diet improved nutrition, balance and body strength in community-dwelling older adults, according to results a randomized controlled trial published in Nutrients.
Apitegromab linked to improved outcomes for those with spinal muscular atrophy
Treatment with apitegromab was linked to improved muscle strength and range of motion, while being safe and well-tolerated in those with spinal muscular atrophy types 2 and 3, according to a poster presentation.
Treatment with antibody oligonucleotide conjugate led to improved outcomes in DM1
Long-term treatment with IV administration of a novel therapeutic for those with myotonic dystrophy type 1 led to significant improvement in muscle strength and control and improved quality of life, data show.
More positive data announced in clinical trial for myotonic dystrophy type 1 therapeutic
A Southern California biopharmaceutical company has announced positive data from a phase 1/2 clinical trial of its proprietary monoclonal antibody, AOC 1001, for those with myotonic dystrophy type 1.
No interaction observed between bone, muscle variables for fracture risk for older men
Muscle mass as measured through high-resolution peripheral quantitative CT may not interact with bone measures to affect the risk for fractures among older men, though more studies are needed, according to study data.